{{Chembox
| ImageFile = Liarozole.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = 6-[(3-Chlorophenyl)-imidazol-1-ylmethyl]-1''H''-benzimidazole
| OtherNames = 
|Section1={{Chembox Identifiers
| IUPHAR_ligand = 5210
| CASNo = 115575-11-6
| PubChem = 60652
| SMILES =C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4 
| ChemSpiderID = 54664
| InChI = 1/C17H13ClN4/c18-14-3-1-2-12(8-14)17(22-7-6-19-11-22)13-4-5-15-16(9-13)21-10-20-15/h1-11,17H,(H,20,21)
| InChIKey = UGFHIPBXIWJXNA-UHFFFAOYAV
| StdInChI = 1S/C17H13ClN4/c18-14-3-1-2-12(8-14)17(22-7-6-19-11-22)13-4-5-15-16(9-13)21-10-20-15/h1-11,17H,(H,20,21)
| StdInChIKey = UGFHIPBXIWJXNA-UHFFFAOYSA-N}}
|Section2={{Chembox Properties
| C=17 | H=13 | Cl=1 | N=4
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Liarozole''' is a [[retinoic acid]] metabolism-blocking drug and [[aromatase inhibitor]].<ref>{{cite journal|pmid=24102348|year=2013|last1=Vahlquist|first1=A|last2=Blockhuys|first2=S|last3=Steijlen|first3=P|last4=Van Rossem|first4=K|last5=Didona|first5=B|last6=Blanco|first6=D|last7=Traupe|first7=H|title=Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: Results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial|doi=10.1111/bjd.12626|journal=The British journal of dermatology|pages=173â€“81|volume=170|issue=1}}</ref>

==Synthesis==
[[File:Liarozole synthesis.png|thumb|left|600px|Liarozole synthesis from Lednicer book 6 (Drugs of the Future citation).]]{{Clear}}

==References==
{{Reflist|2}}


{{Retinoid receptor modulators}}

[[Category:Aromatase inhibitors]]
[[Category:Benzimidazoles]]
[[Category:Chloroarenes]]
[[Category:CYP17A1 inhibitors]]
[[Category:Imidazoles]]


{{organic-compound-stub}}
{{pharma-stub}}